Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Prevention Epicenter Publications

Bloodstream Infections

  1. Camins BC, Richmond AM, Krahl KE, McMullen K, Rothstein M, Fraser VJ (2008).  Modifiable Risk Factors for Development of Bloodstream Infections Among Hemodialysis Patients. American Journal of Infection Control. In press.
  2. Climo M, Diekema D, Warren DK, Herwaldt LA, Perl TM, Peterson L, Plaskett T, Price C, Sepkowitz K, Solomon S, Tokars J, Fraser VJ, Wong E (2003, December). Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infection Control and Hospital Epidemiology, 24(12):942-5.
  3. Diekema DJ, Lee K, Raney P, Herwaldt LA, Doern GV, and Tenover FC (2004. Accuracy and Appropriateness of Antimicrobial Susceptibility Test Reporting for Bacteria Isolated from Blood Cultures.  Journal of Clinical Microbiology, 42:2258-2260. DOI: 10.1128/JCM.42.5.2258-2260.2004.
  4. Lin MY, Weinstein RA, Hota B (2008). Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrobial Agents Chemotherapy, 52(9):3188-94.

Clostridium difficile Infection

  1. Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, D’Angelo G, McDonald LC, Fraser VJ (2008). Attributable Outcomes of Endemic Clostridium difficile-associated Disease in Nonsurgical Patients. Emerging Infectious Diseases, 14 (7):1031-8.
  2. Dubberke E, Butler A, Hota B, Khan Y, Mangino J, Mayer J, Popovich K, Stevenson K, Yokoe D, McDonald C, Jernigan J, Fraser V (2009). Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for Clostridium difficile infection. Infection Control and Hospital Epidemiology, 30(6):518-25.
  3. Litvin M, Reske K, Mayfield J, McMullen K, Georgantopoulos P, Copper S, Hoppe-Bauer J, Fraser V, Warren D, Dubberke E (2009). Identification of a Pseudo-Outbreak of Clostridium difficile Infection (CDI) and the Effect of Repeated Testing, Sensitivity, and Specificity on Perceived Prevalence of CDI. Infection Control and Hospital Epidemiology, 20:1166-1171.
  4. Dubberke E, McMullen K, Mayfield J, Reske K, Georgantopoulos P, Warren D, Fraser V (2009). Hospital-associated Clostridium difficile Infection: Is It Necessary to Track Community-Onset Disease? Infection Control and Hospital Epidemiology, 30:332-
  5. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ (2008). Short and Long-Term Attributable Costs of Clostridium difficile-associated Disease in Nonsurgical Inpatients. Clinical Infectious Diseases, 46:497-504. DOI: 10.1086/526530.
  6. Dubberke ER, Wertheimer AI (2009). Review of Current Literature on the Economic Burden of Clostridium difficile Infection. Infection Control and Hospital Epidemiology, 30(1):57–66.
  7. Sohn S, Climo M, Diekema D, Fraser V, Herwaldt L, Marino S, Noskin G, Perl T, Song X, Tokars J, Warren D, Wong E, Yokoe DS, Zembower T, Sepkowitz KA, and Prevention Epicenter Hospitals. (2005, August). Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals.  Infection Control and Hospital Epidemiology, 26(8):676-9.

Top of page

Use of Chlorhexidine Bathing to Prevent Healthcare-associated Infections

  1. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, and Weinstein RA (2007). Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Archives of Internal Medicine, 167(19):2073-9.
  2. Climo MW, Septowitz KA, Zucotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES (2009). The Effect of daily bathing with Chlorhexidine on the Acquisition of Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci and Healthcare-associated Bloodstream Infections: Results of a Quasi-experimental Multicenter Trial. Critical Care Medicine, 37(6):1858-65.
  3. Popovich K, Hota B, Hayes R, Weinstein R, Hayden M (2009). Effectiveness of routine Patient Cleansing with Chlorhexidine Gluconate for Infection Prevention in the Medical Intensive Care Unit. Infection Control and Hospital Epidemiology, 30(10):959-963.

Top of page

Methicillin-resistant Staphylococcus aureus and other Resistant Organisms

  1. Climo M, Sepkowitz K, Zuccotti G, Fraser V, Warren D, Perl T, Speck K, Jernigan J, Bush A, Wong E (2009). Daily Bathing with Chlorhexidine Reduces the Acquisition of Methicillin- resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and Healthcare- associated Bloodstream Infections: Results of a Multicenter Trial. Critical Care Medicine, 37(6):1858-65
  2. Data R, Huang, SS (2008). Risk of Infection and Death due to Methicillin-resistant Staphylococcus aureus in Long-term Carriers. Clinical Infectious Diseases, 47(2):176-81.
  3. Evans RS, Wallace CJ, Lloyd JF, Taylor CW, Abouzelof RH, Sumner S, Johnson KW, Wuthrich A, Harbarth S, Samore MH (2008). Rapid Identification of Hospitalized Patients at High Risk for MRSA Carriage.  Journal of the American Medical Informatics Association, 15(4): 506-512. DOI:10.1197/jamia.M2721.
  4. Hota B, Ellenbogen C, Hayden M, Aroutcheva A, Rice T, Weinstein R (2007). Community associated Methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Archives of Internal Medicine, 167(10): 1026-33.
  5. Huang SS, Diekema DJ, Warren DK, Zuccotti G, Winokur PL, Tendolkar S, Boyken L, Datta R, Jones RB, Ward M, Aubrey T, Onderdonk AB, Garcia C, Platt R  (2008). Strain-Relatedness of Methicillin-resistant Staphylococcus aureus Isolates from Patients with Repeated Infection. Clinical Infectious Diseases, 46(8):1241–7.
  6. Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES,  Cosgrove SE, Perl TM, Pottinger JM, Herwaldt LA, Jernigan JA, Tokars JL, Diekema DJ, Hinrichsen VL, Yokoe DS, Platt R (2007, February). Improving Methicillin-resistant Staphylococcus aureus Surveillance and Reporting in Intensive Care Units. Journal of Infectious Diseases, 195(3):330-8.
  7. Huang SS, Platt R (2003, February). Risk of Methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Journal of Clinical Infectious Diseases, 36(3):281-5.
  8. Huang SS, Diekema D, Warren D, Zuccotti G, Winokur P, Tendolkar S, Ward M, Datta R, Jones R, Boyken L, Aubrey T, Onderdone A, Platt R (2008). Strain-relatedness of Methicillin-resistant Staphylococcus aureus isolates from patients with repeated infection. Clinical Infectious Diseases, 46(8):1241-7.
  9. McMullen K, Warren D, Woeltje K (2009). The Changing Susceptibilities of Methicillin-resistant Staphylococcus aureusat a Midwestern Hospital: The Emergence of “Community- Associated” MRSA. American Journal of Infection Control, 37(6):454-7.
  10. Popovich K (2009). Staphylococcus aureus: Not Always Right Under Your Nose. Infection Control and Hospital Epidemiology, 30(8):272-729.
  11. Popovich K, Hota B (2008). The Treatment and Prevention of Community-associated methicilin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Dermatological Therapy, 21(3):167-79, 1396-0296.
  12. Popovich K, Hota B, Weinstein R (2008). Treatment of Community-associated Methicillin-resistant Staphylococcus aureus. Current Infection Diseases, 9(5):398-407. Current Infectious Disease Report, 10(5):411-20.
  13. Popvich K, Hota B, Rice T, Aroutcheva A, Weinstein R (2007). Phenotypic Prediction Rule for Community-associated Methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology, 45(7) :2293-5.
  14. Popovich K, Weinstein R (2009). The Graying of Methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology, 30(1):9-12.
  15. Popovich KJ, Weinstein RA, and Hota B (2008). Are community-associated Methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clinical Infectious Diseases, 46(6):787-94.

Top of page

Surgical Site Infections

  1. Apisarnthanarak A, Jones M, Waterman BM, Carroll CM, Bernardi R, Fraser VJ (2003). Risk factors for spinal surgical site infections in a community hospital: A case-control study. Infection Control and Hospital Epidemiology, 24:31-6. DOI: 10.1086/502197
  2. Bolon M, Hooper D, Stevenson K, Greenbaum M, Olsen M, Platt R, Herwaldt L, Noskin G, Fraser V, Climo M, Khan Y, Vostok J, Yokoe D (2009). Improved Surveillance for Surgical Site Infection Following Orthopedic Implant Procedures: Extending Applications for Automated Data. Clinical Infectious Diseases, 48:1223-9.
  3. Hooper DC, Sands KE, Tully J, Herwaldt LA, Diekema DJ, Wong ES, Climo M, Platt R (2004). Enhanced identification of postoperative infections among inpatients. Emerging Infectious Diseases, 10:1924-1930.
  4. Olsen M, Higham-Kessler J, Yokoe D, Butler A, Stevenson K, Khan Y, Fraser V (2009). Developing a Risk Stratification Model for Surgical Site Infection after abdominal Hysterectomy. Infection Control and Hospital Epidemiology, 30:1077-83.
  5. Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ  (2008). Risk factors for surgical site infection following low transverse cesarean section.  Infection Control and Hospital Epidemiology, 29(6):477-84.
  6. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VF (2008). Hospital-associated costs due to surgical site infection after breast surgery.  Archives of Surgery,143:53-60.
  7. Olsen MA, Krauss M, Agniel D, Schootman M, Gentry CN, Yan Y, Damiano RJ Jr., Fraser VJ (2008). Mortality associated with bloodstream infection following coronary artery bypass surgery.  Clinical Infectious Diseases, 46:1537-46.
  8. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield JL, Fraser VJ (2007). Risk factors for surgical site infection following orthopaedic spinal operations. The Journal of Bone and Joint Surgery, 90:62-69. DOI:10.2106/JBJS.F.01515.
  9. Yokoe DS, Noskin GA, Cunningham SM, Zuccotti G, Plaskett T, Fraser VJ, Olsen MA, Tokars N, Solomon S, Perl TM, Cosgrove SE, Tilson RS, Greenbaum M, Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VF (2008).  Risk factors for surgical site infection after major breast operation.  Journal of the American College of Surgeons, 207:326-35.

Top of page

Ventilator-associated Pneumonia

  1. Klompas M, Kleinman K, Platt R (2008). Development of an Algorithm for Surveillance of Ventilator-associated Pneumonia With Electronic Data and Comparison of Algorithm Results With Clinician Diagnoses. Infection Control and Hospital Epidemiology, 29(1):31-7.

Top of page

Antimicrobial Utilization

  1. Lin M, Weinstein R, and Hota B (2008). Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. [PDF 73 KB] Antimicrobial Agents Chemotherapy, 52(9): 3188-94.
  2. Camins B, King M, Wells J, Googe H, Patel M, Kourbatova E, Blumberg H (2009). Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital: A Randomized Controlled Trial. Infection Control and Hospital Epidemiology, 30(10):931-938.

Top of page

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #